HomeNewsBusinessReal EstateConsolidation to be the new normal for the real estate sector post COVID-19

Consolidation to be the new normal for the real estate sector post COVID-19

Not all real estate firms will be able to weather the storm leading to large scale consolidation. It would first hit smaller towns and gradually shift to metros

August 26, 2020 / 15:25 IST
Story continues below Advertisement

Will real estate survive the economic impact of the lockdown? The answer is ‘yes’. Once the economy rebounds, it will enhance demand for commercial real estate which in turn will drive growth in other segments of the sector, including residential, which is already witnessing some changes in the post-COVID-19 world.

The ‘new normal’ in the COVID-19 era in terms of problems and prospects, translates into a radically changed situation for the economy, real estate is one sector where existing challenges have been enhanced as a result of the pandemic.

Story continues below Advertisement

To ensure survival and growth, ‘last mile funding’ for stressed, delayed and incomplete projects awaits quick resolution while a one-time roll-over to restructure debt as also extension of moratorium along with a quick-fix of the broken supply chain are new entries to the ‘must-do’ list.

In the post-COVID-19 world, the first requirement is survival, and while the authorities have done well so far, more needs to be done – and at the earliest.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show